Loomis Sayles & CO L P Embecta Corp. Transaction History

Loomis Sayles & CO L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$12.35 - $19.33 $1.77 Million - $2.76 Million	-143,005 Reduced 74.41%	49,176 $653,000
Q4 2023 Feb 13, 2024	SELL	$12.87 - $19.09 $347,734 - $515,792	-27,019 Reduced 12.33%	192,181 $3.64 Million
Q3 2023 Nov 09, 2023	SELL	$15.0 - $22.17 $70,485 - $104,176	-4,699 Reduced 2.1%	219,200 $3.3 Million
Q2 2023 Aug 11, 2023	BUY	$21.6 - $30.69 $693,360 - $985,149	32,100 Added 16.74%	223,899 $4.84 Million
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $4.42 Million - $6.29 Million	191,799 New	191,799 $5.39 Million

401

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.11B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.